Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06465277

CMR Right Ventricular Contractile Reserve Following Lung Resection

Assessment of Right Ventricular Contractile Reserve Following Lung Resection by Dobutamine Stress Cardiac Magnetic Resonance: a Feasibility Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
42 (estimated)
Sponsor
Belfast Health and Social Care Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Feasibility study investigating CMR dobutamine stress testing before and after lung resection

Detailed description

We hypothesise that following lung resection, 1. the subtle decrease in RV function and increase in afterload we have demonstrated at rest is associated with a marked impairment of RV function on exercise, termed impaired RV contractile reserve (RVCreserve), 2. impaired RVCreserve is associated with impaired functional capacity . In this study we aim to assess the feasibility of dobutamine stress cardiovascular magnetic resonance (CMR) scanning to assess RVCreserve pre- and post-operatively in patients undergoing lung resection. Additionally, we hypothesise that one lung ventilation (with and without lung resection) is associated with biomarker evidence of RV injury.We will perform peri-operative cardiac biomarkers to differentiate between the contribution of major surgery (gastrectomy, lung resection and oesophagectomy), one lung ventilation (lung resection and oesophagectomy) and lung resection on RV injury.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDobutamine stress CMRDobutamine stress testing will be undertaken in keeping with local departmental clinical guidelines with a graded increase in dobutamine infusion up to a maximum of 10microgram/kg/min. The patients' medications will be managed in keeping with the usual clinical practice and departmental guidelines. At rest and on each graded level of dobutamine infusion we will collect cine loops of the cardiac cycle including a short-axis stack of the ventricles, a four-chamber view and flow imaging perpendicular to the main, left and right pulmonary arteries. Post-processing will be dual reported by blinded observers using the Argus analysis software (Siemens) according to a standardised protocol. A safety report of each CMR scan will be generated by a consultant cardiologist, any abnormalities identified will be referred to the appropriate medical speciality and highlighted to the patient's clinical team.
DIAGNOSTIC_TESTCardiac biomarker sampleblood samples will be collected pre-operatively, in recovery, on post-operative days 1 and 2, and at 4-8 weeks post-operatively

Timeline

Start date
2023-07-21
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2024-06-18
Last updated
2024-10-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06465277. Inclusion in this directory is not an endorsement.